+29.1%
MRNA vs FITB
+129.2%
-100.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FITB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +0.4% | +0.3% | +0.6% |
| 7D | -8.2% | -1.0% | -7.2% | -8.0% |
| 30D | +125.6% | -5.5% | +131.1% | +127.6% |
| 3M | +197.1% | +4.1% | +193.0% | +183.3% |
| 6M | +148.5% | +18.7% | +129.8% | +118.9% |
| YTD | +363.3% | +18.2% | +345.1% | +305.7% |
| 1Y | +462.0% | +23.7% | +438.3% | +377.1% |
| All | +29.1% | +129.2% | -100.1% | -20.6% |
Cumulative growth
Daily Returns
Daily percentage return beside FITB.
Daily Out/Under-Performance
Portfolio return minus FITB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling